Long-term cost-utility analysis of family therapy vs. treatment as usual for young people seen after self-harm.

Chris Bojke David Cottrell Alexandra Wright-Hughes Amanda J Farrin Sandy Tubeuf

Published in: Cost effectiveness and resource allocation : C/E (2024)

Whilst extended trial follow-up from routinely collected statistics is useful to improve the modelling of longer-term cost-effectiveness, FT is not cost-effective relative to TAU and dominated in a cost-utility analysis.

Keyphrases

study protocol
clinical trial
preterm infants
stem cells
randomized controlled trial
cerebrospinal fluid
gestational age
mesenchymal stem cells
open label